Therefore, if you hear someone talking about an injection for weight loss and diabetes, they are referring to GLP-1 receptor agonists like semaglutide or tirzepatide, not insulin
Eli Lilly expects to complete remaining trials throughout 2026, with potential approval submission late 2026 How does GLP 3 retatrutide differ from Ozempic or Mounjaro
Kramer CM, Borlaug BA, Zile MR, et al (2024) Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
GLP-1s do not relieve stress or treat the underlying stressors. It is possible that GLP-1s can help suppress emotional eating: Esposito says that the feeling of fullness they provide could make overeating in response to emotional stress less desirable
Inject subcutaneously
Both of these actions regulate blood sugar levels, which is why these drugs were initially intended to tackle diabetes